Table 5 Determination of antitumor activity

(a) Inhibitory activity against hepatocellularcarcinoma cells was under these experimental conditions with IC₅₀ = 6.67 ± 0.75 µg/ml

 500

1.97

98.03

0.31

 250

4.52

95.48

0.26

 125

9.73

90.27

0.95

 62.5

17.40

82.6

1.42

 31.25

26.35

73.65

1.73

 15.6

35.42

64.58

1.64

 7.8

42.97

57.03

2.59

 3.9

67.21

32.79

2.37

 2

80.36

19.64

1.08

 1

89.42

10.58

0.84

 0

100

0

0

(b) Inhibitory activity against breast carcinoma cells was detected under these experimental conditions with IC₅₀ = 291.1 ± 9.54 µg/ml

 500

28.63

71.37

3.95

 250

54.21

45.79

2.43

 125

83.59

16.41

1.73

 62.5

98.64

1.36

0.82

 31.25

100

0

0

 15.6

100

0

0

 0

100

0

0